OpenAI GPT-Rosalind: The AI Model Accelerating Drug Discovery in 2026
OpenAI launched GPT-Rosalind on April 16, 2026 — a frontier AI model purpose-built for biology, drug discovery, and translational medicine research. Here is what it can do and why it matters. Continue reading the full article on WowHow → Originally published at https://wowhow.cloud/blogs/openai-gpt-rosalind-drug-discovery-life-sciences-ai-2026